Status:
NOT_YET_RECRUITING
Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit
Lead Sponsor:
Assiut University
Conditions:
Neonatal Hyperbilirubinemia
Eligibility:
All Genders
1-28 years
Brief Summary
Early detection and prevention of neonatal encephalopathy using BIND score.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Newborn \< 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion
- Exclusion criteria:
- Age \> 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).
Exclusion
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07150494
Start Date
October 1 2025
End Date
October 1 2026
Last Update
September 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.